EMA Taking Steps To Mitigate ‘Critical’ Product Shortages Due To GMP Problems

The EMA is consulting on changes to the template for declaring non-compliance with good manufacturing practice, as the first step in a revision of the procedures for handling GMP-related shortages of “critical” medicines.